Geri
Marvel Biosciences Corp. (MBCOF) Fiyatı
MBCOF Hisse Senedi Fiyat Grafiği
MBCOF Kazanmak
Marvel Biosciences Corp.
$0.09
0.62%
$0
Kapanışta: Jan 23, 16:00:00 GMT-5
$0.09
0%
$0
Sonrası Piyasa: Jan 23, 20:00:00 GMT-5
Earnings FAQ
MBCOF'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Marvel Biosciences Corp. MBCOF'ün son çeyrekteki geliri nasıl performans gösterdi?
Marvel Biosciences Corp.'in gelir tahmini nedir?
Marvel Biosciences Corp.'in kazanç kalite puanı nedir?
Marvel Biosciences Corp. kazançlarını ne zaman rapor eder?
Marvel Biosciences Corp.'in beklenen kazançları nelerdir?
Marvel Biosciences Corp. kazanç beklentilerini aştı mı?
Önemli İstatistikler
Önceki Kapanış
$0.096
Açılış fiyatı
$0.0966
Günün Aralığı
$0.0966 - $0.0966
52 haftalık aralık
$0.046 - $0.241
İşlem hacmi
5.0K
Ort.Hacim
12.5K
EPS (TTM)
-0.04
Dividend yield
--
Piyasa Değeri
$5.6M
MARVEL BIOSCIENCES CORP. nedir?
Marvel Biosciences Corp. is a biotechnology company that utilizes a drug redevelopment approach to drug development. The company is headquartered in Calgary, Alberta. The company went IPO on 2019-02-28. The firm develops new synthetic chemical derivatives of the original approved drug for the new disease indication. The company has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs that inhibit the A2a adenosine receptor with application to neurological diseases (depression and anxiety, Alzheimer's, attention deficit hyperactivity disorder (ADHD)), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The firm's lead compound, MB-204, is a fluorinated derivative of Istradefylline. The firm is engaged in developing MB-204 for diseases other than Parkinson's disease, specifically depression, Alzheimer’s Disease and liver fibrosis due to non-alcoholic steatohepatitis (NASH). Its wholly owned subsidiary is Marvel Biotechnology Inc.
Özellikler
Ticaret Stratejileri
Kaynaklar
© 2025 Finture Development Limited. All rights reserved